Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science
The goal of this study is to identify genes that convey susceptibility to congenital diaphragmatic hernia in humans. The identification of such genes, and examination of their structure and function, will enable a delineation of molecular pathogenesis and, ultimately, prevention or treatment of congenital diaphragmatic hernia. There are many different possible modes of inheritance for congenital anomalies, including autosomal dominant, autosomal recessive, and multifactorial. Multi-factorial inheritance is responsible for many common medical disorders, including hypertension, myocardial infarction, diabetes and cancer. This type of inheritance pattern appears to involve environmental factors as well as a combination of genetic variations that together can predispose to or produce congenital anomalies, such as congenital diaphragmatic hernia. Our study is designed to establish a small, well-defined genetic resource consisting of 1) Nuclear families suitable for linkage analysis by parametric,non-parametric (e.g. sib pairs, TDT) and association techniques, 2) Individuals with congenital diaphragmatic hernia who can be directly screened for allelic variation in candidate genes, and 3) Individuals who can serve as controls (are unaffected by congenital diaphragmatic hernia). Neonates and their families will be collected from homogenous and heterogeneous populations. By characterizing diverse populations, it should be possible to increase the likelihood of demonstration of genetic variation in selected candidate genes that can then be used in association and linkage studies in individual subjects with congenital diaphragmatic hernia.
Conditions:
🦠 Congenital Diaphragmatic Hernia
🗓️ Study Start (Actual) June 2005
🗓️ Primary Completion (Estimated) November 2025
✅ Study Completion (Estimated) November 2025
👥 Enrollment (Estimated) 3000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Chicago, Illinois, United States
📍 Ann Arbor, Michigan, United States
📍 Saint Louis, Missouri, United States
📍 Omaha, Nebraska, United States
📍 Manhasset, New York, United States
📍 New York, New York, United States
📍 New York, New York, United States
📍 Cincinnati, Ohio, United States
📍 Portland, Oregon, United States
📍 Pittsburgh, Pennsylvania, United States
📍 Nashville, Tennessee, United States
📍 Dallas, Texas, United States
📍 Milwaukee, Wisconsin, United States
📍 Cairo, Egypt

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of a CDH

    Exclusion Criteria:

    • * Individuals with no personal history of a CDH or family history of a family member affected with congenital diaphragmatic hernia
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 29 July 2009
  • First Submitted that Met QC Criteria 30 July 2009
  • First Posted 31 July 2009

Study Record Updates

  • Last Update Submitted that Met QC Criteria 30 April 2024
  • Last Update Posted 1 May 2024
  • Last Verified April 2024